Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-06 · accession 0000950170-24-070250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-06 | HRTX | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +12.5K | 95.4K | +15% | — |
| D | 2024-06-07 | 2024-06-06 | HRTX | Forbes William P | EVP, Chief Development Off | M - OptEx | $0.00 | -12.5K | 37.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-06 | M | A | 12,500 | — | 95,374 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Derivative | Restricted Stock Units | 2024-06-06 | M | D | 12,500 | $0.00 | 37,500 | D | $0.00 · — to — | 12,500 Common Stock | (F2) The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. |